Daniel Kotz’s research while affiliated with Universitätsklinikum Düsseldorf and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (254)


Key elements of the OptiCor project including the systematic development and evaluation of the complex intervention, based on the Medical Research Council (MRC) guidelines [31] (WP: work package)
Study flow of the planned cluster randomised controlled trial (O = no training). A study cycle consists of 10 weeks of data collection: 5 weeks patients of “control” and 5 weeks in patients of “intervention” general practitioners (GPs). In total there will be five cycles resulting in 50 practices (25 intervention and 25 control practices)
Optimising the treatment of chronic ischemic heart disease by training general practitioners to deliver very brief advice on physical activity (OptiCor): protocol of the systematic development and evaluation of a complex intervention
  • Article
  • Full-text available

November 2024

·

17 Reads

BMC Primary Care

Sabrina Hoppe

·

Alicia Prinz

·

Rik Crutzen

·

[...]

·

Background Chronic ischemic heart disease (IHD) is one of the leading causes of morbidity and mortality. Physical activity (PA) is an effective secondary preventive strategy in IHD management. The German treatment guideline recommends that general practitioners (GPs) deliver PA advice to patients. This recommendation seems inadequately implemented, often due to GP’s insufficient specific training. International guidelines recommend training GPs in how to deliver such advice effectively and efficiently. Evidence is lacking on whether such training can enhance the frequency and quality of PA advice in routine care. The OptiCor project aims to develop and evaluate a GP training in the delivery of very brief PA advice to optimise the treatment of patients with IHD in general practice. Methods OptiCor comprises three study phases according to the Medical Research Council recommendations for developing and evaluating complex interventions. Phase 1 (needs analysis): A nationwide representative household survey will be conducted to collect data on the receipt of GP-delivered PA advice in people with IHD. Qualitative interviews and group discussions with GPs and people with IHD will help to explore, e.g., attitudes, experiences with, and barriers and facilitators of PA advice implementation or reception, respectively. Findings will inform the training development. Phase 2 (pilot): A pragmatic cluster randomised controlled trial (cRCT) on the effectiveness of the developed training on proportions of GP-delivered PA advice during routine care of IHD patients will be piloted. Phase 3 (evaluation): A full pragmatic cRCT will be conducted with patient-reported proportions of GP-delivered PA advice as primary endpoint. Collection of health economic and process-related data will facilitate a potential future broad implementation and health economic evaluation of the training. Discussion If the developed training successfully improves proportions and quality of GP delivered PA advice to patients with IHD, it could serve as a low-threshold and sustainable strategy for implementing PA recommendations in the secondary prevention of IHD in routine GP practice. Trial registration Work package (WP) 1, WP5, and WP6 have been prospectively registered at German Clinical Trials Register (WP1: DRKS00031304, 19/06/2023; WP5: DRKS00034641, 10/07/2024; WP6: DRKS00034642; 10/07/2024).

Download

Disposable e‐cigarettes: Prevalence of use in Germany from 2016 to 2023 and associated user characteristics

November 2024

·

9 Reads

Addiction

Aims To provide data on prevalence and trends in the use of different types of e‐cigarettes (disposable, pod, tank) in Germany (a country with high smoking prevalence of approximately 30%) from 2016 to 2023, and to analyse the characteristics and smoking behaviours of users of these types. Design A series of nationally representative cross‐sectional face‐to‐face household surveys. Setting General population of Germany, 2016–2023. Participants A total of 92 327 people (aged ≥14 years) of which 1398 reported current use of e‐cigarettes. Measurements Type of e‐cigarette usually used (single choice: disposable, pod, or tank), person characteristics, and smoking/vaping behaviour. Findings E‐cigarette use in the population of Germany has increased from 1.6% (95% confidence interval [CI] = 1.1,2.2) in 2016 to 2.2% (95% CI = 1.6,3.0) at the end of 2023. Disposable e‐cigarette use has increased in this period from 0.1% (95% CI = 0.0,0.3) to 0.8% (95% CI = 0.4,1.8). Pod type use exhibited the most stable trend, with a steady rise to 0.6% (95% CI = 0.4,0.9) in 2023. Tank e‐cigarette use peaked at 1.6% (95% CI = 1.3,1.9) in November 2017, declined to 0.7% (95% CI = 0.6,0.9) in December 2020, and has since remained constant at 0.8% (95% CI = 0.6,1.0). Disposable e‐cigarette users were on average 3.5 and 4.1 years younger than tank and pod users, respectively. They were more likely than tank users to be female, non‐daily users, and dual users of tobacco. In the subgroup of dual users, there were no significant differences with regard to urges to smoke, cigarettes smoked per day, motivation to stop, and attempts to stop smoking between users of disposables and other types. Conclusions The use of e‐cigarettes has increased in Germany from 2016 to 2023, especially that of disposable e‐cigarettes, which are now the most commonly used type with a prevalence rate of 0.8%. However, the use of e‐cigarettes is still much lower compared with tobacco smoking.


45 Optimising the management of chronic ischemic heart disease by training general practitioners to deliver very brief advice on physical activity (OptiCor)

September 2024

·

7 Reads

The European Journal of Public Health

Purpose The German treatment guideline “chronic ischemic/coronary heart disease (IHD)” recommends that general practitioners (GPs) deliver advice on physical activity (PA) to IHD patients. This recommendation is inadequately implemented, often due to GP’s insufficient specific training. International guidelines recommend training GPs in how to deliver PA advice effectively and efficiently. Evidence is lacking on how such training should be designed to match the recipients’ needs, and whether it improves the frequency and quality of advice. With OptiCor we aim to systematically develop and evaluate such a training for GPs to optimise the routine care of IHD patients. Project OptiCor has started in 2022. It comprises three phases over five years. The methodology matches the Medical Research Council framework recommendations for complex interventions. GPs and patients are substantially involved throughout the entire project. OptiCor (funded by the German Ministry of Education and Research) will be presented internationally for the first time. Phase 1 (needs analysis/development)–completed: A nationwide, face-to-face household survey was used to collect data on the receipt of GP-delivered PA advice in people with IHD. Focus group discussions and problem-centred interviews were conducted with GPs and patients with IHD to explore attitudes and motivation towards, experiences with, and barriers and facilitators of PA advice implementation or reception, respectively. The findings are now being used to inform the theory-based training development. Phase 2 (pilot): A pragmatic cluster randomised controlled trial (cRCT) on the effectiveness of the GP training on delivered PA advice during routine care of IHD patients will be pilot tested in summer 2024. Phase 3 (evaluation): A full pragmatic cRCT will be conducted from 2025 onwards (primary endpoint: patient-reported proportions of GP-delivered PA advice). Health economic and process-related analyses will facilitate a potential future broad dissemination and health economic evaluation of the training. Conclusions If our training successfully enhances the proportions and quality of delivered PA advice to IHD patients, it represents a low-threshold strategy for a broad implementation in general practice. The training could extend existing projects on PA referral/prescription schemes, and it could be transferred to the management of other diseases or to other healthcare settings.


99 Delivery of advice on physical activity by general practitioners in Germany: a cross-sectional population survey in people with chronic ischemic heart disease (OptiCor study)

September 2024

·

4 Reads

The European Journal of Public Health

Purpose The current German treatment guideline “chronic ischemic heart disease (IHD)” recommends that general practitioners (GPs) deliver advice on physical activity (PA) to patients with IHD. Such advice is particularly effective in motivating individuals to increase their PA when it consists of three elements: (1) asking for/assessing the PA level, (2) advising on PA, and (3) assisting with PA (e.g., providing concrete support/recommendations). However, in Germany, current and representative data on the receipt of these elements of GP advice in individuals with IHD is lacking. This study aims at collecting such data on a population level. Methods Nationwide, computer-assisted, face-to-face cross-sectional survey of ≃1000 individuals (35+ years) with self-reported IHD on the receipt of the three elements of GP advice on PA (ask/assess, advise, assist) since their last remembered IHD-event/intervention (e.g., myocardial infarction, stent insertion). The survey started in June 2023 and will continue until May 2024. Six of eight survey waves have been completed. When the complete data set is available, associations with person characteristics (e.g., sex, income, region of living, body mass index, PA level) will be analysed using adjusted regression models. Results on the associations will be presented at the conference. Results Of the current sample of 682 individuals with IHD, 35.3% (95% confidence interval (CI) = 32-39) received all three elements of GP advice (ask/assess, advise, assist), 44.4% (95%CI = 41-48) received one or two elements (e.g., ask/assess only), and 10.0% (95%CI = 8-12) received any advice (2.9% received the advice to refrain from PA, 7.3% did not remember/refused to answer). Men (38.0%; 95%CI = 34-43) versus women (30.5%; 95%CI = 25-36), individuals from urban (40.7%; 95%CI = 36-46) versus rural regions (26.2%; 95%CI = 21-32), and those with a PA level of 1-149 minutes/week (43.1%; 95%CI = 36-51) and of 150+ minutes/week (39.0%; 95%CI = 31-47) versus non-active individuals (20.7%; 95%CI = 15-28) reported the receipt of all elements of PA advice more often. Conclusions In Germany, about one third of individuals with IHD received all relevant elements of GP advice on PA since their last IHD-event/intervention. In order to increase the delivery and enhance the effectiveness of GP advice, target group-specific measures need to be implemented. Funding German Ministry of Education and Research (01GY2103).




Physical activity and tobacco smoking in the German adult population

August 2024

·

12 Reads

Background Physical inactivity and tobacco smoking remain leading causes of morbidity and mortality worldwide. In Germany, smoking prevalence is high at around 30% and only 45% achieve the World Health Organization recommendation for physical activity (PA). Understanding how smoking and physical inactivity co-occur can inform interventions targeting these behaviours. Methods We analysed data from 4,073 adults (≥18 years) participating in a national household survey between April and July 2022. We tested the association between PA level (not=reference/low/medium/very active) and smoking status (never=reference/ex/current smoker). Among current smokers, we tested associations between PA level and cigarettes smoked per day; time spent with, and strength of, urges to smoke; and motivation to stop smoking. Results Overall, 29.9% (95%CI=28.5;31.4) reported no leisure time PA; among current smokers it was 39.8% (95% CI=37.3;42.4). Higher PA levels were associated with lower odds of being a current vs. never smoker (OR=0.74, 95%CI=0.69;0.79). Among current smokers, higher PA levels were associated with smoking fewer cigarettes per day (β=-0.98,95%CI=-1.39;-0.56), weaker urges to smoke (OR=0.81,95%CI=0.74;0.89), and higher motivation to stop smoking (OR=1.13,95%CI=1.02;1.24). Time spent with urges to smoke showed a small overlap in the upper CI (OR=0.93,95%CI=0.85;1.02). Conclusion People who are more physically active are less likely to smoke. Current smokers with higher PA levels smoke less, are less dependent, and more motivated to quit. Further research is required to determine whether these associations are causal and, if so, whether interventions to increase PA could help people to quit smoking.


What proportion of cannabis users in Germany have spoken with their general practitioner about their consumption? A repeated cross-sectional representative population survey

July 2024

·

19 Reads

Introduction On 1st of April 2024 a law on cannabis legislation entered into force in Germany. Henceforth, a rise in cannabis consumption rates and consequently cannabis related health impacts is expected. Preventive measures are only possible if harmful use is recognised and addressed at an early stage. We set up to estimate the proportion of cannabis users in Germany that discussed their cannabis consumption with their general practitioner (GP), either on the initiative of the GP or the patient, and how these varied according to person characteristics. Methods We used data from the German Study on Tobacco Use (DEBRA). This is a repeated ongoing representative cross-sectional household survey on use of tobacco and alternative nicotine delivery systems in Germany in people aged 14 years and older. During bimonthly study waves we asked all respondents who stated that they had consumed cannabis before whether they had ever spoken with their GP about their cannabis use or received advice about it. We estimated the proportion including 95% confidence intervals and assessed possible associations with person characteristics by using univariate logistic regression models. Results Of 2,057 ever users of cannabis, 7.0% [95%CI = 5.9; 8.2%] (n = 139) answered “Yes, I have ever spoken to my general practitioner about my cannabis use or sought advice in this regard”. This response was associated with older age (65+), low educational attainment, low income, and frequent cannabis use. Conversation with a GP was also more common in past-year cannabis users (16.2% [95%CI = 13.5; 19.6%], n = 591). Conclusions Around one in fifteen cannabis users has ever spoken with his or her GP, or received advice, about his or her cannabis consumption. In past-year and frequent users, the proportions are highest, between 16 to 26%. The awareness of this topic among GPs needs to be increased. Furthermore, a future re-evaluation on what impact the legislation of cannabis will have on the frequency of consultation about cannabis consumption in primary care is necessary.


Implementierung der Tabakentwöhnung in den Workflow des Lungenkrebsscreenings in Deutschland: Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP)

July 2024

·

14 Reads

Pneumologie

Zusammenfassung Sowohl die Tabakentwöhnung als auch ein Low-dose-CT-Screening bei Risikopersonen senken die lungenkrebsspezifische Mortalität und die Gesamtmortalität. Im Rahmen eines nationalen Screeningprogramms zur Früherkennung von Lungenkrebs muss die Tabakentwöhnung obligater Bestandteil der Beratung der Teilnehmenden sein. Hierdurch wird auch die Kosten-Nutzen-Effektivität des Screeningprogramms gesteigert. Im Rahmen des Erstgesprächs müssen Teilnehmenden des Screeningprogramms in Form einer Minimalintervention evidenzbasierte Maßnahmen zur Tabakentwöhnung angeboten werden. Bei nicht gewünschter Tabakentwöhnung müssen Teilnehmende des Screeningprogramms aktiv widersprechen (Opt-out-Regelung). Die Kosten für die Tabakentwöhnung inklusive der Kosten für eine entzugshemmende Medikation sind durch die Gesetzliche Krankenversicherung vollständig zu übernehmen.


Smokers’ perception of the comparative health risks of cigarettes, e-cigarettes and heated tobacco products: a survey among the German population

May 2024

·

23 Reads

·

2 Citations

Journal of Public Health

Background Tobacco cigarettes, e-cigarettes and heated tobacco products can pose different health risks (harm continuum). As current tobacco smokers could benefit from switching to less harmful products, we aimed to assess current smokers’ perceived comparative health risks of these three products and to explore associations between risk perceptions and specific user characteristics. Methods We analysed data from 11 waves (2019–2021; N = 5657 current tobacco smokers) of a representative, cross-sectional household survey conducted in Germany. Associations were assessed with multivariable logistic regression models. Results 55.2% of smokers (95%CI = 53.8–56.5%) ranked cigarettes as the most harmful product. 36.1% of smokers (95%CI = 34.8–37.3%) perceived e-cigarettes and 33.8% (95%CI = 32.5–35.0%) heated tobacco products as more harmful than cigarettes. Misperceptions that e-cigarettes or heated tobacco products are more harmful to health than cigarettes increased over the 3-year study period and were more common among those with lower educational attainment. Conclusions Only half of current tobacco smokers in Germany perceive the comparative health risks of cigarettes adequately and such misperceptions have increased recently. As current smokers could benefit most from switching to less harmful products, educational campaigns are needed to inform this group about the health risks of tobacco smoking and the comparative health risks of the various nicotine and tobacco products along the harm continuum.


Citations (55)


... In addition, acute exposure in the laboratory allows for the occurrence of a more serious close epithelial disease of COVID-19 by reducing the mucosal innate immune response and proliferation of airway basal dendritic cells and has implications for the spread and severity of disease in exposed subjects to cigarette smoke, with more severe viral infection and cell death. [24,25] Smoking patients with various comorbidities are more susceptible to infection with COVID-19 and have a worse prognosis for the virus as well as for their comorbidities. [26] Further investigation into the interaction between smoking and COVID-19 is warranted to accurately assess the risk of developing COVID-19 among smokers, and progression to mechanical ventilation or death in COVID-19 patients. ...

Reference:

Incidence of Covid-19 Infection among Smokers in Kirkuk, Iraq
Associations between Tobacco Smoking and Self-Reported SARS-CoV-2/COVID-19 Infections, Disease Severity, and Duration in the German Population

SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice

... We recently showed that at least one in twenty residents in Germany consumed cannabis during the past year, with a higher prevalence among younger people. 2 Consumption rates have increased during the past two to three decades and are expected to rise further. 3 The change in law could enhance this trend since, apart from decriminalisation of possession, the availability of cannabis is simpli ed. ...

Cannabis Use in Germany: Frequency, Routes of Administration, and Co-use of Inhaled Nicotine or Tobacco Products
  • Citing Article
  • January 2024

Deutsches Ärzteblatt international

... In the COPD population, the prevalence of depression is estimated at 40%; however, depression is missed by practitioners in approximately 50% of patients [4]. It is known that psychological distress is more prevalent in the COPD population, in comparison to the general population [5]. For this reason, it is said that COPD and depression have a bidirectional relationship [6]. ...

Attempts to quit smoking, use of smoking cessation methods, and associated characteristics among COPD patients

npj Primary Care Respiratory Medicine

... The effectiveness of behavioural and pharmacological components of stop smoking care is well-established, [3,4] and offering help to stop smoking is an evidencebased tobacco control policy integral to the World Health Organization's "MPOWER" model [5]. Despite this, even though intention to stop is high among people who smoke, many do not have access to or use stop smoking supports [6][7][8][9][10]. ...

Financial incentives for sustained smoking abstinence in pregnancy
  • Citing Article
  • October 2022

The BMJ

... We know that a similar pattern regarding alcohol consumption exists. 17 People from higher socio-demographic groups might nd it harder to admit consumption due to stigmatisation or GPs might expect use more often in lower sociodemographic groups. Frequeny of actually visiting one's GP is likely to have an in uence as well. ...

Prevalence and characteristics of hazardous and harmful drinkers receiving general practitioners’ brief advice on and support with alcohol consumption in Germany: results of a population survey

BMJ Open

... 10 In a series of papers, we have analysed data accumulated from a growing sample of smokers to compare the success rates of those trying to quit with different aids, adjusting for a wide range of potential confounders (e.g., level of addiction and other features of the quit attempt). [11][12][13][14][15][16] The largest analysis to date included 18,929 participants surveyed up to July 2018 and suggested using e-cigarettes or varenicline were the most effective methods: after adjustment for covariates and use of other aids, participants who used these in their most recent past-year quit attempt had 1.95 and 1.82 times higher odds, respectively, of still being abstinent at the time of the survey than those who did not. 11 There was little evidence that effectiveness differed by socioeconomic position, with the exception of websites, which appeared more effective for smokers from more disadvantaged social grades compared with those from more advantaged social grades. ...

Real-world effectiveness of smoking cessation aids: A population survey in England with 12-month follow-up, 2015–2020

Addictive Behaviors

... In fact, it's often considered the preferred treatment option in many countries, including Germany, as highlighted in national treatment guidelines. 17 Lopez-Olivo et al., study found that a notable interest among smokers in exploring hypnotherapy as a potential tool for smoking cessation. 18 Hypnosis-based cognitive behavioral intervention is effectiveness on smoking cessation and self-efficacy increasing which also reduces the amount of anxiety. ...

S3 Guideline "Smoking and Tobacco Dependence: Screening, Diagnosis, and Treatment" - Short Version

European Addiction Research

... A study investigating behavior changes during the COVID-19 pandemic in Spring 2020 in Germany found that 18.5 % of the population increased their PA, while 29.4 % decreased it. People who increased PA were more often female and had higher education (Klosterhalfen et al., 2022). In our study, 75 % of participants was female, 68 % had a university entrance qualification but we did not find associations between PA and gender or PA or educational level. ...

Did Smoking, Alcohol Consumption, and Physical Activity Change during the COVID-19 Restrictions in Germany in Spring 2020?

SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice

... Hinzu kommen methodisch vergleichbare Studien, die sich schwerpunktmäßig oder ausschließlich einer Substanz widmen, wie z. B. die Deutsche Befragung zum Rauchverhalten (DEBRA, seit 2016) [15,[31][32][33]. Die Längsschnittstudien (ALS, DAS, DEBRA, ESA) sowie die ergänzenden Primärstudien sind in ▶tab. 2 hinsichtlich der Gesamtstichprobengröße, der Altersspanne der Stichproben und der erfassten Substanz(en)/ Substanzgruppe(n) dargestellt. ...

Recreational Cannabidiol: Awareness, Prevalence of use, and Associated Factors in a Representative Sample of the German Population
  • Citing Article
  • June 2022

... 14 Several prediction models have been developed for COPD readmissions or mortality risk. [15][16][17][18] Furthermore, the increasing hospitalization frequency has been shown to increase the risk of mortality. 7 Therefore, given the importance of these two outcomes (hospitalization and mortality due to COPD) and their intrinsic relationship, joint modeling of both processes is necessary for two reasons. ...

Development and validation of a multivariable mortality risk prediction model for COPD in primary care

npj Primary Care Respiratory Medicine